APA (7th ed.) Citation

T, B., G, P., L, T., C, V., JD, C., AM, P., . . . RS, K. (2023). Engineering active lysostaphin variants that incorporate noncanonical amino acids and characterizing the effects of site-specific PEGylation. Biotechnology and bioengineering, 120(6), 1694. https://doi.org/10.1002/bit.28360

Chicago Style (17th ed.) Citation

T, Batugal, et al. "Engineering Active Lysostaphin Variants That Incorporate Noncanonical Amino Acids and Characterizing the Effects of Site-specific PEGylation." Biotechnology and Bioengineering 120, no. 6 (2023): 1694. https://doi.org/10.1002/bit.28360.

MLA (9th ed.) Citation

T, Batugal, et al. "Engineering Active Lysostaphin Variants That Incorporate Noncanonical Amino Acids and Characterizing the Effects of Site-specific PEGylation." Biotechnology and Bioengineering, vol. 120, no. 6, 2023, p. 1694, https://doi.org/10.1002/bit.28360.